www.uhnresearch.ca
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Proof of Concept
Fund:
Compass Rose
Novel T-cell Immunotherapy (autologous cellular therapy)
Related news
[contact-form-7 id="0b0c7a8" title="General Contact"]